Israel Englander An2 Therapeutics, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 50,038 shares of ANTX stock, worth $53,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,038
Previous 209,366
76.1%
Holding current value
$53,040
Previous $284,000
76.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ANTX
# of Institutions
37Shares Held
8.56MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.39 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.1 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1MShares$1.06 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY583KShares$617,7360.62% of portfolio
-
Stonepine Capital Management, LLC Bend, OR544KShares$577,1630.57% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $20.6M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...